Quick Answer
Biofrontera Inc. reported Diluted EPS of $1.04 per share (loss) for fiscal year 2025.
Biofrontera Inc. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$1.04 | +67.7% |
| 2024 | -$3.22 | +75.3% |
| 2023 | -$13.02 | -2034.4% |
| 2022 | -$0.61 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$0.62 | +36.7% | -8.8% |
| June 30, 2025 | -$0.57 | -1040.0% | -21.3% |
| March 31, 2025 | -$0.47 | +83.7% | +52.0% |
| September 30, 2024 | -$0.98 | +78.9% | -1860.0% |
| June 30, 2024 | -$0.05 | +99.3% | +98.3% |
| March 31, 2024 | -$2.88 | +48.6% | +37.9% |
| September 30, 2023 | -$4.64 | -105.3% | +35.8% |
| June 30, 2023 | -$7.23 | -703.3% | -29.1% |
- Biofrontera Inc. showed an increase of +67.7% in Diluted EPS compared to the prior fiscal year.
- Over the 2022–2025 period, Biofrontera Inc.’s diluted eps has declined by 70.5% (from $0.61 per share (loss) to $1.04 per share (loss)).
- The most recent figure is from Biofrontera Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 19, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: